SGMT Long Call Strategy

SGMT (Sagimet Biosciences Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.

SGMT (Sagimet Biosciences Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $247.6M, a beta of 3.64 versus the broader market, a 52-week range of 3.08-11.41, average daily share volume of 1.4M, a public-listing history dating back to 2023, approximately 14 full-time employees. These structural characteristics shape how SGMT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 3.64 indicates SGMT has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a long call on SGMT?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current SGMT snapshot

As of May 15, 2026, spot at $6.92, ATM IV 85.10%, IV rank 8.25%, expected move 24.40%. The long call on SGMT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long call structure on SGMT specifically: SGMT IV at 85.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a SGMT long call, with a market-implied 1-standard-deviation move of approximately 24.40% (roughly $1.69 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SGMT expiries trade a higher absolute premium for lower per-day decay. Position sizing on SGMT should anchor to the underlying notional of $6.92 per share and to the trader's directional view on SGMT stock.

SGMT long call setup

The SGMT long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SGMT near $6.92, the first option leg uses a $6.92 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SGMT chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SGMT shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$6.92N/A

SGMT long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

SGMT long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on SGMT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on SGMT

Long calls on SGMT express a bullish thesis with defined risk; traders use them ahead of SGMT catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

SGMT thesis for this long call

The market-implied 1-standard-deviation range for SGMT extends from approximately $5.23 on the downside to $8.61 on the upside. A SGMT long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current SGMT IV rank near 8.25% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on SGMT at 85.10%. As a Healthcare name, SGMT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SGMT-specific events.

SGMT long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SGMT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SGMT alongside the broader basket even when SGMT-specific fundamentals are unchanged. Long-premium structures like a long call on SGMT are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current SGMT chain quotes before placing a trade.

Frequently asked questions

What is a long call on SGMT?
A long call on SGMT is the long call strategy applied to SGMT (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With SGMT stock trading near $6.92, the strikes shown on this page are snapped to the nearest listed SGMT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are SGMT long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the SGMT long call priced from the end-of-day chain at a 30-day expiry (ATM IV 85.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a SGMT long call?
The breakeven for the SGMT long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SGMT market-implied 1-standard-deviation expected move is approximately 24.40%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on SGMT?
Long calls on SGMT express a bullish thesis with defined risk; traders use them ahead of SGMT catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current SGMT implied volatility affect this long call?
SGMT ATM IV is at 85.10% with IV rank near 8.25%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related SGMT analysis